tiprankstipranks

Robert Cascella Insider Profile

235 Followers
Robert Cascella, CEO & President, Director at Hologic, holds 98.16K shares in REPRO-MED Systems (Ticker: KRMD), holds 625.02K shares in Neuronetics (Ticker: STIM), holds 60.80K shares in Mirion Technologies (Ticker: MIR).
tipranks
Robert Cascella

Robert Cascella
Hologic (HOLX)
CEO & President, Director

Ranked #1,254 out of 108,079 Corporate Insiders

Profitable Transactions

71%
5 out of 7 Profitable Transactions

Average Return

+115.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
46.03%
34.30%
17.41%
2.26%
A breakdown of Robert Cascella's holdings

Insider Roles

Mirion Technologies
(MIR)
Director
Neuronetics
(STIM)
Director
REPRO-MED Systems
(KRMD)
Director
Celestica
(CLS)
Director
Roles that Robert Cascella holds in companies

Most Profitable Insider Trade

Stock:
Neuronetics
(STIM)
Rating:Informative Buy
Date:Sep 13, 2024 - Sep 13, 2025
Return:+327.40%
The most profitable trade made by Robert Cascella

Robert Cascella's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
HOLX
Hologic
Jul 02, 2013
Uninformative Sell
391.00K
$30.51M
Neuronetics
May 29, 2026
Director
Uninformative Buy
$812.52K
Mirion Technologies
May 14, 2026
Director
Uninformative Buy
$1.09M
REPRO-MED Systems
Jul 01, 2026
Director
Uninformative Buy
15.00K
$412.25K
Celestica
Apr 02, 2026
Director
Uninformative Buy
37.82K
$53.63K
List of latest transactions for each holding click on a transaction to see Robert Cascella's performance on stock

Robert Cascella insider profile FAQ

What is the percentage of profitable transactions made by Robert Cascella?
The percentage of profitable transactions made by Robert Cascella is 71%.
    What is the average return per transaction made by Robert Cascella?
    The average return per transaction made by Robert Cascella is 115.10%.
      What stocks does Robert Cascella hold?
      Robert Cascella holds: HOLX, STIM, MIR, KRMD, CLS stocks.
        What was Robert Cascella’s latest transaction?
        Robert Cascella latest transaction was an Uninformative Buy of $15.00K.
          What was Robert Cascella's most profitable transaction?
          Robert Cascella’s most profitable transaction was an Informative Buy of STIM stock on September 13, 2024. The return on the trade was 327.40%.
            What is Robert Cascella's role in Hologic?
            Robert Cascella's role in Hologic is CEO & President, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.